文献速递病毒性肝炎

DASH快速PCR系统HCV RNA即时检测方法的开发

Development of a Rapid Automated Point-of-Care Test for Hepatitis C Viral RNA on the DASH Rapid Polymerase Chain Reaction System.
PubMed 文献 · J Infect Dis · 2026-01-01

本研究在DASH快速PCR系统上开发15分钟出结果的定性HCV RNA即时检测,分析性能显示可检测基因1-6型、检测限200 IU/mL(100 μL样本),97份血浆标本初步临床验证与商业平台阳性及阴性符合率均为100%。

要点

  • DASH HCV检测15分钟出结果,检测限200 IU/mL(100 μL样本)。
  • 可等效检测HCV基因1-6型,动态范围宽。
  • 97份血浆标本与商业平台阳性、阴性符合率均100%。

核心结论

  • DASH HCV检测有望支持HCV当日诊断与治疗,助力消除目标。

研究设计与样本

  • 评估DASH快速PCR系统上15分钟出结果的定性HCV分子检测的分析性能。
  • 评估动态范围、检测限、分析特异性及基因1-6型等效检测。
  • 约翰霍普金斯大学研究者用回顾性收集标本独立开展小型临床验证,共97份血浆标本。

主要发现

  • 研究用DASH HCV检测动态范围宽,可检测HCV基因1-6型。
  • 检测限为200 IU/mL,样本加样体积100 μL。
  • 97份血浆标本中,与商业平台比较阳性符合率和阴性符合率均为100%。

关键数值与推荐

  • 检测限200 IU/mL(100 μL样本加样)。
  • 97份血浆标本阳性符合率100%、阴性符合率100%。

临床怎么用

  • 该检测为定性分子检测,15分钟出结果,适合即时检测场景。
  • 初步验证支持其用于HCV RNA检测以辅助当日诊断与治疗。

局限性

  • 临床验证为小型、回顾性收集标本的初步研究,共97份血浆标本。
  • 所评估检测为研究用途(Research Use Only)版本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hepatitis C virus (HCV) infection is a major public health problem despite the availability of highly effective and curative direct-acting antiviral treatments. Low diagnostic rates, driven in part by a 2-step diagnostic process and the need for molecular confirmation, pose a significant barrier to timely treatment. Here we describe the development, analytical characterization, and a preliminary clinical validation study of a rapid, user-friendly, sensitive, qualitative molecular test for point-of-care HCV testing. METHODS: This study evaluated the analytical performance of a 15-minute time to result qualitative molecular test for HCV on the sample-to-answer point-of-care DASH Rapid PCR System. The dynamic range, limit of detection, analytical specificity, and the equivalent detection of genotypes 1-6 were assessed. A small clinical validation study was independently conducted by Johns Hopkins University investigators using retrospectively collected specimens. RESULTS: The Research Use Only DASH HCV assay has wide dynamic range, can detect HCV genotypes 1-6, and has a detection limit of 200 IU/mL with 100 μL specimen volume addition. In a preliminary study of 97 plasma specimens, the DASH HCV assay demonstrated 100% positive percent agreement and 100% negative percent agreement when compared to commercial platforms. CONCLUSIONS: The DASH HCV test holds potential to enable same-day diagnosis and treatment in support of HCV elimination efforts.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Reed JL, Butzler MA, Hawkins CA, et al. Development of a Rapid Automated Point-of-Care Test for Hepatitis C Viral RNA on the DASH Rapid Polymerase Chain Reaction System. J Infect Dis. 2026. PMID: 41369203. doi:10.1093/infdis/jiaf608

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。